the LittleCat

Chuncheon, South Korea

the LittleCat is a healthcare startup dedicated to communicating with pets through healthcare data, focusing on developing global AI healthcare solution service platforms based on big data construction and analysis of pet biometric information. They offer healthcare devices and app services such as the B612 Cat Planet exercise system, INPET smart cat wheel, and MediSand, which helps monitor kidney health through cat litter. The company is committed to creating solutions that address the unspoken health statuses of pets by leveraging IoT, AI, and Big Data technologies. They hold several international intellectual property registrations and have received numerous recognitions, including the CES2024 Product Innovation Award from the American Consumer Technology Association.

✓Source: HealthTech Alpha by Galen Growth

Shareable draft

Check out the LittleCat on @MedStartr Today #KidneyHealthAndNutrition #KidneyDisease #Veterinary #MonitoringDevices #AIML #MedMo #MedStartrVentures

https://www.medstartr.ai/s/EoS0sUx1j5Y

Get Involved in the LittleCat

🏢Is this your company? Claim This Profile

Join MedStartr to verify with your work email and edit this profile

Company Info

Founded: 2018
Website: www.thelittlecat.kr/

Disease Areas

Kidney Health and Nutrition Kidney Disease

Technologies

IoTAI/Machine LearningBig DataAnimal Health

🌐Website

MedStartr Engagement Score

The MedStartr Index is a reflection of how the crowds that come to MedStartr everyday to find healthcare innovations reacted. Calculated by our AI agent Fyggy based on algorithms we have been building since 2012 and over 100 different factors, the math is proprietary and complex. Suffice to say, it has been found to be highly correlative with early stage company growth. What you see here is the public version. To learn more or to get deeper access to our predictive data on startup success for your fund or company, click here.

Comments

Comments from new members are shown once the company's team has approved them. Please follow the community rules.

Be the first to comment.

What do you think of the LittleCat?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Submit anonymously — my name won't be shown to the team or on this profile

Your scores and comments are shown with your review on this company's profile.